ACS nano

Alternative Lipids Improve mRNA Treatment Effectiveness with Repeated Doses and Boost Delivery to Immune Cells

Updated

Abstract

PAM-LNPs achieve 300% mRNA expression compared to PEG-LNPs after repeated dosing.

  • PAM-lipids are introduced as alternatives to PEG-lipids in mRNA lipid nanoparticle formulations.
  • Variations in PAM monomer chemistry can reduce cross-reactivity with anti-PEG antibodies.
  • Certain PAM-LNPs show improved mRNA delivery to dendritic cells and macrophages, enhancing transfection efficacy.
  • Lead PAM-LNPs demonstrate significant increases in mRNA delivery efficiency across various cell types and tissues.
  • PAM-LNPs can successfully evade anti-PEG antibodies, potentially maintaining therapeutic efficacy in repeat dosing scenarios.

Simplified

Full Text

Full text is available at the source.

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • ✅direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free